Abstract
Neoadjuvant chemotherapy (NAC), followed by surgery and adjuvant therapy, constitutes the prevailing therapeutic paradigm for patients with locally advanced breast cancer (LABC)
Funding Information
  • Academic Leaders Training Program of Pudong Health Bureau of Shanghai (PWRd2024-06, 2025-PWXZ-12, 82173115, 82103695, 20DZ2201600, 22QC1400200, 202340085)
  • New Quality Clinical Specialty Program of High-end Medical Disciplinary Construction in Shanghai Pudong New Area (PWRd2024-06, 2025-PWXZ-12, 82173115, 82103695, 20DZ2201600, 22QC1400200, 202340085)
  • National Natural Science Foundation of China (PWRd2024-06, 2025-PWXZ-12, 82173115, 82103695, 20DZ2201600, 22QC1400200, 202340085)
  • Science and Technology Commission of Shanghai Municipality (PWRd2024-06, 2025-PWXZ-12, 82173115, 82103695, 20DZ2201600, 22QC1400200, 202340085)
  • Shanghai Municipal Key Clinical Specialty, Shanghai Rising-Star Program (PWRd2024-06, 2025-PWXZ-12, 82173115, 82103695, 20DZ2201600, 22QC1400200, 202340085)
  • Shanghai Municipal Health Commission Health Industry Clinical Research Special Project (PWRd2024-06, 2025-PWXZ-12, 82173115, 82103695, 20DZ2201600, 22QC1400200, 202340085)

This publication has 41 references indexed in Scilit: